Hernia-Prophylaxis in Acute Care Surgery H-PACS
- Conditions
- Incisional Hernia
- Registration Number
- NCT03090022
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Brief Summary
Incisional hernia is a common complication in visceral surgery and varies between 11 and 26% in the general surgical population. Patients requiring emergency laparotomy are at high risk for the development of incisional hernia and fascial dehiscence. Among this population the incidence of incisional hernia in patients undergoing emergency surgery varies between 33-54%. Incisional hernias are associated with a high morbidity rate, such as intestinal incarceration, chronic discomfort, pain, and reoperation and typically require implantation of a synthetic mesh in a later second operation. Fascial dehiscence represents an acute form of dehiscence and has been observed in up to 24.1% and is associated with a mortality rate up to 44%.
The gold standard for abdominal wall closure during elective and emergency operations is a running slowly absorbable suture. In the elective situation it has been shown that prophylactic mesh implantation in high risk patients reduced the incidence of incisional hernia significantly.
The investigators and others have shown that mesh implantation in patients undergoing emergency laparotomy or in contaminated abdominal cavities are safe .
With a randomized controlled trial the investigators now aim to compare the incidence of incisional hernia after prophylactic mesh implantation versus standard of care in patients requiring emergency laparotomy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 61
- Patients undergoing emergency midline laparatomy
- Emergency laparoscopy with expected conversion to midline laparatomy
- Written informed consent
- ASA ≥5
- Septic shock
- Pregnant women
- Prior mesh Implantation
- Known sensitivity for porcine material or Polysorbate 20
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of incidence of death up to 18 months follow-up
Number of patients with hernia free survival up to 18 months follow-up
- Secondary Outcome Measures
Name Time Method Number of postoperative intestinal fistulas 30 days follow-up
Number of small bowel obstructions 18 months follow-up
Number of postoperative mesh explantations 18 months follow-up
Number of postoperative mortality 90 days survival
Number of surgical site infections postoperative 30 days follow-up
Number of postoperative mesh infections 18 months follow-up
Number of patients with postoperative pain 18 months follow-up
Number of patients with postoperative fascial dehiscence 30 days follow-up
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Dep. of Visceral and transplant surgery, Berne University Hospital
🇨🇭Berne, Switzerland
Dep. of Visceral and transplant surgery, Berne University Hospital🇨🇭Berne, Switzerland